Nohria A, Alonso RA, Peattie DA: Identification and characterization of gamma-giardin and the gamma-giardin gene from Giardia lamblia. Mol Biochem Parasitol

1992,56(1):27–37.PubMedCrossRef 25. Steuart RF, O’Handley R, Lipscombe SP600125 RJ, Lock RA, Thompson RC: Alpha 2 giardin is an assemblage A-specific protein of human infective Giardia duodenalis. Parasitology 2008,135(14):1621–1627.PubMedCrossRef 26. Guimaraes S, Sogayar MI, Franco M: Analysis of proteins from membrane and soluble fractions of Giardia duodenalis trophozoites of two Brazilian axenic strains. Rev Inst Med Trop Sao Paulo 2002,44(5):239–244.PubMedCrossRef 27. Davis-Hayman SR, Nash TE: Genetic manipulation of Giardia lamblia. Mol Biochem Parasitol 2002,122(1):1–7.PubMedCrossRef 28. Diamond LS, Harlow DR, Cunnick CC: A new medium for the axenic cultivation of Entamoeba histolytica and other Entamoeba. Trans R Soc Trop Med Hyg 1978,72(4):431–432.PubMedCrossRef 29. Keister DB: Axenic culture of Giardia lamblia in TYI-S-33 medium supplemented with bile. Trans R Soc Trop Med Hyg 1983,77(4):487–488.PubMedCrossRef 30. Hellman U: Peptide mapping using

MALDI-TOFMS. In Mass spectrometry and hyphenated techniques in neuropeptide research. Edited by: Silberring JaER. John Wiley & Sons, Inc.; 2002:259–275. 31. Palm JE, Weiland ME, Griffiths WJ, Ljungstrom I, Svard SG: Identification of immunoreactive proteins during acute human giardiasis. J Infect Dis 2003,187(12):1849–1859.PubMedCrossRef 32. Tellez A, Palm D, Weiland M, Aleman J, Winiecka-Krusnell J, Linder E, Svard S: Secretory

antibodies against Giardia intestinalis in lactating Selleck Fludarabine Nicaraguan women. Parasite Immunol 2005,27(5):163–169.PubMedCrossRef 33. Nash TE, Lujan HT, Mowatt MR, Conrad JT: Variant-specific surface protein switching in Giardia lamblia. Infect Immun 2001,69(3):1922–1923.PubMedCrossRef 34. Taylor GD, Wenman WM: Human immune response to Giardia lamblia infection. J Infect Dis 1987,155(1):137–140.PubMedCrossRef 35. Janoff EN, Craft JC, Pickering LK, Novotny T, Blaser MJ, Knisley CV, Reller LB: Diagnosis of Giardia lamblia Staurosporine concentration infections by detection of parasite-specific antigens. J Clin Microbiol 1989,27(3):431–435.PubMed 36. Char S, Shetty N, Narasimha M, Elliott E, Macaden R, Farthing MJ: Serum antibody response in children with Giardia lamblia infection and identification of an immunodominant 57-kilodalton antigen. Parasite Immunol 1991,13(3):329–337.PubMedCrossRef 37. Holberton DV: Arrangement of subunits in microribbons from Giardia. J Cell Sci 1981, 47:167–185.PubMed 38. Crossley R, Holberton D: Assembly of 2.5 nm filaments from giardin, a protein associated with cytoskeletal microtubules in Giardia. J Cell Sci 1985, 78:205–231.PubMed 39. Holberton DV: Fine structure of the ventral disk apparatus and the mechanism of attachment in the flagellate Giardia muris. J Cell Sci 1973,13(1):11–41.PubMed 40.

Lanes are molecular size marker, M; cultures after 0 day, 0; 6 days, 6; 8 days, 8; 10 days, 10; 12 days, 12; 14 days, 14; and 14 days cultivation in the absence of alkanes, -. b, Relative degradation of alkanes by strain B23. Fractions degraded were estimated by the reduction of peak areas in GC/FID. Figure 3 Effects of long-chain alkanes on the induction Selleckchem Lorlatinib levels of P24, P21 and P16. Proteins were separated on an SDS-12% polyacrylamide gel and stained with Coomassie Brilliant Blue R-250. Lanes are molecular size marker (M), total cellular proteins

in the absence of alkanes (-); total cellular proteins in the presence of decane (C10), tetradecane (C14), octadecane (C18), docosane (C22), hexacosane (C26), triacontane (C30), tetracontane (C34). The effect of carbon chain length of alkanes on the induction FK228 ic50 levels of the proteins was examined. It is obvious that the induction

effect increases in accordance with the increase in the chain length of alkanes (Fig. 3). It has previously been shown that strain B23 effectively degrades alkanes longer than dodecane [1]. These results strongly suggest that P24, P21, and P16 are related to the long-chain-alkane degradation by strain B23 or the production of these proteins was stimulated in the consequence of alkane degradation. Localization of the proteins in the cell was examined by fractionation of total cellular proteins (Fig. 4). Because P24 was recovered in a soluble fraction after disruption of the cells, this protein is probably a cytoplasmic protein. On the other hand, P21 and P16 were recovered in an insoluble form, suggesting that they are membrane proteins. Figure 4 Localization of P24, P21, and P16 in the cells. Lanes are molecular weight markers, M; whole cell fraction cultivated in the absence of alkanes, 1; whole cell fraction cultivated in the presence of alkanes, 2. Soluble

intracellular fraction after sonication of the cells, 3; insoluble membrane fraction after sonication, 4. Amino acid sequences of P21 and P16 The N-terminal amino acid sequences of P21 and P16 were determined as AFPLSGVGGFTISADLI (P21-N) and VPISGVGEFXVTFDKL (P16-N), respectively. These sequences, which are Anacetrapib highly similar with each other, showed considerable similarity with that of cholesterol esterase from Streptomyces lavendulae [15]. Cholesterol esterase is a secretion enzyme which hydrolyzes long-chain fatty acid esters of cholesterol and mainly functions in mammalian tissues. In bacteria, only actinomycetes and pseudomonads [16] are reported to produce this enzyme. Cloning and analysis of genes encoding P21 and P16 Utilizing the information of N-terminal and internal amino acid sequences, 416 bp and 1.8 kb DNA fragments encoding a part of P21 and P16, respectively, were cloned and their nucleotide sequence was determined.

b + indicates pks15/1 gene intact. c -indicates absence of the RD105 genomic region. By origin, 22 of the 26 isolates were from foreign-born cases (84.6%) of nine different nationalities, the most frequent being Peruvians and Ecuadorians (42%). The remaining four Beijing isolates corresponded to autochthonous cases (Table 1).

The drug susceptibility tests showed that 23 of the 26 isolates were pan-susceptible, two were isoniazid-resistant, and one was multidrug-resistant (Table 1). Genotyping analysis The IS6110-RFLP analysis revealed 21 different genotypes (9-22 IS6110 copies). Seven isolates (26.9%) were grouped in two clusters of three and four cases each. Nineteen isolates (73.1%) were unclustered and considered orphan cases (Figure 1A). The isolates involved in cluster 2 (C2) shared an identical IS6110-RFLP pattern Ibrutinib with those involved in the Gran Canaria outbreak [14]. Figure 1 Comparative analysis of IS 6110 -RFLP (A), MIRU-15 (B), and MIRU-15+5 (C) in the 26 clinical Beijing isolates. aOrder of QUB loci: QUB 11a, QUB 3232, and QUB 18. bOrder of VNTR loci: VNTR3820 and VNTR4120. The clustered cases are indicated within boxes. C1 and C2 refer to the cases included in the two clusters defined by RFLP. In some cases, the large

size of some products obtained in QUB and the VNTR loci did not allow precise assignation of alleles. In these cases we could only estimate that the

number of repetitions was higher than 20 (> 20). Y-27632 datasheet When we observed products differing in size in groups of isolates with more than Cyclic nucleotide phosphodiesterase 20 repetitions, we sub-labeled them > 20a, > 20b, > 20c and > 20d. The MIRU-15 analysis identified 18 different genotypes among the Beijing isolates. Thirteen isolates (50%) were grouped in five clusters of two or three cases. The remaining isolates corresponded to orphan cases (Figure 1B). If we compare RFLP and MIRU-15 data, it is noteworthy that two representatives of cluster 1 (C1), defined by RFLP, were split by MIRU-15, and three of the clusters defined by MIRU-15 grouped isolates that had been considered orphan by RFLP. Only the C2 cluster defined by RFLP remained intact after MIRU analysis. Regarding the isolates clustered in C2, which shared the RFLP pattern with the isolate involved in the Gran Canaria outbreak, we also pursued to compare the MIRU-15 data. With this aim, a selection of Gran Canaria outbreak isolates, sharing also the susceptibility pattern with those form Madrid, were analyzed and an identical MIRU-15 type was shared by the representatives from Madrid and Gran Canaria. After observing the low discrimination of MIRU-15, five new VNTR loci (QUB11a, QUB3232, QUB18, VNTR3820, and VNTR4120) were added; they were all selected due to their high discriminatory values in different studies focused on Beijing isolates [19, 20].

Lymphoma is the most common malignant cause, representing about 60% of all cases, with the non-Hodgkins variant being the most prevalent. Traumatic injuries to the upper abdomen and chest including those sustained during surgery are the second leading cause of chylothorax, accounting for approximately PD0325901 mw 25% of cases. The first traumatic injury to the thoracic duct was described in 1875 and the first thoracic duct ligation

was performed in 1948 [6]. The traumatic causes of injury to the duct vary widely, and the most common blunt mechanism producing injury is related to sudden hyperextension of the spine with rupture of the duct just above the diaphragm [4, 7–9]. Sudden selleck stretching over the vertebral bodies for any reason may tear the duct, but this usually occurs in the setting of a thoracic duct previously affected by disease [4, 8]. Episodes of vomiting or a violent bout of coughing resulting in shearing of the lymphatic conduit along the crux of the right diaphragm has been reported as well

[9]. Penetrating injuries, from a gunshot or stab wound, are less common and usually associated with severe damage to nearby structures. The pertinent anatomy involved in the development of a chylothorax begins with the cysterna chyli, which is a confluence of lymphatics located in the retroperitoneum, just to the right of the posteromedial aorta at the level of the renal

arteries. The thoracic duct ascends from this level and enters the chest through the aortic hiatus into the right hemithorax. The duct crosses over to the left chest at the fourth and fifth thoracic levels and enters the neck anterior to the left subclavian artery to join the venous system at the junction of the left subclavian vein and left internal jugular vein [10, 11, 13]. Knowledge of this anatomy should alert the physician to the possibility of a thoracic duct injury with thoracic spine fractures or any associated upper abdomen or chest injury involving this trajectory. As in this case, the diagnosis of a chyle leak was supported by a pleural fluid triglyceride level greater than 110 mg/dL. A pleural fluid triglyceride concentration less Progesterone than 50 mg/dL excludes a chylothorax. An intermediate level between 50 and 110 mg/dL should be followed by lipoprotein analysis to inspect the pleural fluid for chylomicrons or cholesterol crystals. The presence of chylomicrons and the absence of cholesterol crystals confirm a chyle leak. In addition, a ratio of pleural fluid cholesterol to triglyceride of less than 1 is also diagnostic [11, 12]. Although most cases of traumatic chylothorax can be managed non-operatively, the need for surgical intervention in the subset of patients with associated thoracic fractures is higher and approaches 50 percent [5, 11].

52 Down-regulated         miR-217 2.88±1.15 10.35±3.68 <0.001 3.91±1.36 miR-148a 3.85±1.48 10.39±2.97 <0.001 2.86±0.77 miR-375 4.00±1.55 7.05±1.99 <0.001 1.76±0.36 Data are expressed as the mean ± SD. N: matched normal pancreatic tissue. Determination of prognostic significance of the candidate miRNAs in PDAC The clinicopathological

characteristics of 78 PDAC patients are shown in Table 9. The expression levels of individual miRNAs along with other well-known potential prognostic clinicopathological factors, such as histology, T category, lymph node metastasis, tumour size, perineural Alpelisib cost invasion, venous invasion and margin were included in a univariate analysis. With respect to the miRNA expression levels, for the up-regulated miRNAs, a fold-change of ≥2 was defined as high expression, and a fold-change of <2 was defined as low expression; for the down-regulated miRNAs, a fold-change of ≥2 was defined as low expression, and a fold-change of <2 was defined as high expression. Patients with advanced disease (UICC stage IV and concomitance of distant metastases) were excluded because we assumed that the prognosis of these patients (n=8) is determined by the occurrence of relapse or metastasis rather than other biological

characteristics, such as miRNA expression levels. Table 9 Clinicopathological characteristics of 78 PDAC patients Gender   Male 44 (56%) Female 34 (44%) T category   T1 14 (18%) T2 26 (33%) T3 28 (36%) T4 10 (13%) N category   NO 34 (44%) N1 44 (56%) M category   M0 70 (90%) M1 8 (10%) Tumour size   ≥2 cm 42 (54%) selleckchem <2 cm 36 (46%) Histology   Well or moderately differentiated 38 (49%) Poorly differentiated 40 (51%) Perineural invasion   None or slight 46 (59%) Prominent 32 (41%) Venous invasion   None or slight 40 (51%) Prominent 38 (49%) Tumour grade (UICC)   Stage I-IIA 32 (41%) Stage IIB-IV 46 (59%) Resection margin status   R0 32 (41%) R1 46 (59%) Kaplan-Meier survival analysis was used to analyse the association between postoperative survival and the miRNA expression

level, and the resulting curves were divided into two classes (high and low expression in comparison with the mean level of miRNA expression as the threshold), as shown in Figure 2. Figure 2 Kaplan-Meier analysis of overall survival in patients with PDAC based on their dipyridamole expression of miR-155 (A), miR-100 (B), miR-21 (C), miR-221 (D), miR-31 (E), miR-143 (F), miR-23a (G), miR-217 (H), miR-148a (I) and miR-375 (J). p-values are based on the log-rank test. A univariate analysis using the Cox hazard regression model demonstrated that a high expression level of miR-21 (p=0.018, HR=2.610; 95% CI=1.179-5.777) and miR-155 (p=0.035, HR=2.414; 95% CI=1.064-5.478), a low expression level of miR-375 (p=0.022, HR=2.337; 95% CI=1.431-5.066), T category (p=0.039, HR=2.282; 95% CI=1.043-4.994) and margin involvement (p=0.026, HR=2.550; 95% CI=1.120-5.805) are associated with poor patient survival.

The neighbor-joining cluster analysis was employed to assign new subtypes or variants as mentioned by Scheutz et al. [62]. Identification of virulence and adherence factors All STEC isolates were tested by PCR to investigate the presence of astA, hemolysis related genes (ehxA and hlyA), HPI genes (fyuA and irp) and adhesion-related genes (eae, paa, efa1, toxB, lpfA O157/OI-154, lpfA O157/OI-141, lpfA O113, saa, F4, F5, F6, F17, F18 and F41) using the primers listed in Table 3. Antimicrobial susceptibility testing Antimicrobial resistance was determined by the disc diffusion method

[75]. Twelve antimicrobial groups covering 23 antimicrobial agents including penicillins (ampicillin and piperacillin), β-lactam/β-lactamase inhibitor combinations (amoxicillin-clavulanic acid and ampicillin-sulbactam),

Neratinib in vivo cephems (parenteral) (cephalosporins I, II, III, and IV, cefepime, cefotaxime, ceftriaxone, cephalothin selleck screening library and cefuroxime), monobactams (aztreonam), carbapenems (imipenem and meropenem), aminoglycosides (gentamicin, kanamycin and streptomycin), tetracyclines (tetracycline), fluoroquinolones (ciprofloxacin, norfloxacin and levofloxacin), quinolones (nalidixic acid), folate pathway inhibitors (trimethoprim-sulfamethoxazole), phenicols (chloramphenicol) and nitrofurans (nitrofurantoinz) were tested. Results were interpreted using the Clinical and Laboratory Standards Institute (CLSI, 2012) breakpoints, when available. E. coli ATCCR 25922 was used as quality

control. PFGE and MLST STEC isolates were digested RANTES with XbaI and separated by PFGE using the non-O157 STEC PulseNet protocol (http://​www.​pulsenetinternat​ional.​org). Gel images were converted to Tiff files and then analyzed using BioNumerics software (Applied Maths, Sint-Martens-Latem, Belgium). MLST was performed according to the recommendations of the E. coli MLST website (http://​mlst.​ucc.​ie/​mlst/​dbs/​Ecoli) using 7 housekeeping genes (adk, fumC, gyrB, icd, mdh, purA and recA). Alleles and sequence types (STs) were determined following the website instructions [76]. MLST data for the HUS-associated enterohemorrhagic E. coli (HUSEC) collection were obtained from http://​www.​ehec.​org[52]. All human STEC STs from the E. coli MLST databases were downloaded for comparison. A minimum spanning tree based on these STs was generated with BioNumerics software. Four novel alleles, fumC470, gyrB351, icd396 and recA267 were submitted to E. coli MLST website. The sequences obtained in this study have been deposited in GenBank: KC924398 (icd396), KC924399 (gyrB351), KC924400 (fumC470), KC924401 (recA267) and KC339670 (a new variant of stx 2e). Statistical analysis Statistical tests were performed using SAS, Version 9.1 (SAS Institute Inc., Cary, NC., USA). Statistically significant differences were calculated using a χ2 test where appropriate. P values of <0.05 were considered statistically significant.

More recent perspectives of the OA movement were discussed during the seminar held in Granada in May 2010, Open Access to science information: policies for the development of OA in Southern Europe [6], attended Epigenetics Compound Library ic50 by the delegates (researchers and information specialists) of six Mediterranean countries of South Europe (France, Italy, Turkey, Greece, Portugal). This

seminar stressed the importance of the following actions: link the open digital archives to the National Research Anagrafe; guarantee high quality standards of the OA journals; reduce the cost of publications by moving from the paper to the digital publishing; define common standard to facilitate the gathering and aggregation of metadata. Moreover, a new service announced at the Berlin 8 Conference on Open Access held in Beijing

in October 2010 and intended to implement OA strategies is about to be launched by OASIS (Open Access Scholarly Information Sourcebook) in 2011: The open access map [7] a world map and chronology which shows all OA projects, services, initiatives and their development over the last ten years. Open access in Italy As far as Italy is concerned, an important breakthrough for the academic world was marked by the Messina Declaration, in 2004, the first institutional action on the part of the chancellors of the Italian universities in favour of OA. This event represented the starting point of an action towards the statement of policies requiring Autophagy Compound Library screening researchers to deposit their papers in institutional repositories and to publish research articles in OA journals. Among the most recent Italian initiatives aimed at promoting the OA philosophy, it is worth mentioning the launch in 2008 of the Italian wiki on open access [8], conceived as this website a reference point on Italian projects and best practices. Another reference point

is also the DRIVER wiki containing a section devoted to Open access in Italy [9] while the state of the art of the OA initiatives is described in Open Access in Italy: report 2009 offering a wide overview on the ongoing projects and experiences [10]. Open access in science and medicine A decisive impulse to the unrestricted availability of research results (scientific publications and data sets) is represented by the OpenAIRE Project (Open Access Infrastructure for Research in Europe) [11]. This Pilot Project, financed by the European Commission and covering the 27 member states of the European Union, has been conceived to deliver both a technical and a networking infrastructure to the benefit of the research community. The former infrastructure is aimed at collecting and providing access to the research articles reporting on outcomes of FP7 and European Research Council (ERC) projects, while the second one, based on the creation of a European Helpdesk System, has been designed to best support the practice of archiving in each EU member state.

LF/HF ratio

was significantly higher at M5, M6, M7, M8 and M9 of recovery compared to M1 (rest) in CP and significantly increased at M5 of recovery compared to M1 (rest) in EP. Discussion The results obtained in the present study demonstrated that the hydration protocol, despite producing lower alterations in the HRV indices, was insufficient to significantly influence HRV indices during physical exercise. However, during the recovery period it induced significant changes in the cardiac autonomic modulation, promoting faster recovery of HRV indices. During exercise, the analysis of RMSSD (ms) and HF (nu), which predominantly reflects the parasympathetic tone of the ANS [22], showed higher but not significantly increased values when isotonic solution was administered.

Studies indicate that factors linked to decreased vagal modulation in dehydrated individuals Epigenetics Compound Library manufacturer include attenuation of baroreceptor responses, difficulty in maintaining blood pressure and elevated levels of plasma catecholamines during exercise [10, 23, 24]. We expected that these factors may have influenced the lower values of RMSSD (ms) and HF (nu) in CP. Additionally, during exercise SNS activity predominated over vagal activity in both CP and EP. This mechanism occurs to compensate the body’s demands when exposed to exercise [25]. The increase in HR due to increased metabolism is FK506 solubility dmso associated with reduced global HRV

[26], which was also observed in our study. The SDNN index (ms), which reflects global variability, i.e., both vagal and sympathetic modulation [22], was reduced during exercise. The isotonic solution intake produced a smaller, though statistically insignificant, reduction in this index. It is possible that factors leading to the reduction of vagal modulation in dehydrated individuals [10, 23, 24] influenced the SDNN (ms) responses. Reduction in global HRV is expected during exercise [27], since it increases oxyclozanide heart rate, stroke volume, cardiac output and systolic blood pressure, in order to supply the metabolic requirements. This mechanism may explain the LF (nu) increase during exercise, an index that is predominantly modulated by the sympathetic activity [22], and also the LF/HF ratio increase, which expresses the sympathovagal balance [22]. According to Mendonca et al., [28], the increase in the spectral indices suggests sympathetic activation during exercise at low and moderate intensities. Javorka et al., [29] reported similar findings – they investigated the HRV of 17 individuals subjected to 8 min of the step test at 70% maximal potency, and reported reduced SDNN (ms), RMSSD (ms) and HF and increased LF during exercise. During exercise, as a consequence of reduced cardiac vagal activity, the reduction of global HRV is accompanied by a decrease in absolute power (ms2) of the spectral components [26].

J Bacteriol 1993, 175:3259–3268.PubMed 34. Gambello MJ, Iglewski BH: Cloning and characterization of the Pseudomonas aeruginosa lasR gene, a transcriptional activator of elastase expression. J Bacteriol 1991, 173:3000–3009.PubMed 35. McGowan S, Sebaihia M, Jones S, Yu B, Bainton N, Chan PF, Bycroft B, Stewart GS, Williams P, Salmond GP: Carbapenem antibiotic production in Erwinia carotovora is regulated by CarR, a homologue of the LuxR transcriptional activator. Microbiology 1995, 141:541–550.PubMedCrossRef 36. Ducros VM, Lewis RJ, Verma CS, Dodson EJ, Leonard check details G, Turkenburg JP, Murshudov GN, Wilkinson AJ, Brannigan JA: Crystal structure of GerE, the ultimate transcriptional

regulator of spore formation in Bacillus subtilis . J Mol RG7204 ic50 Biol 2001, 306:759–771.PubMedCrossRef 37. Dubern JF, Coppoolse ER, Stiekema WJ, Bloemberg GV: Genetic and functional characterization of the gene cluster directing the biosynthesis of putisolvin I and II in Pseudomonas putida strain PCL1445. Microbiology 2008, 154:2070–2083.PubMedCrossRef 38. Jensen LJ, Kuhn M, Stark M, Chaffron S, Creevey C, Muller J, Doerks T, Julien P, Roth A, Simonovic M, Bork P, von Mering C: STRING 8–a global view on proteins and their functional interactions in 630 organisms. Nucleic Acids Res 2009, 37:D412-D416.PubMedCrossRef 39. Galperin MY, Nikolskaya

AN: Identification of sensory and signal-transducing domains in two-component

signalling systems. Methods Enzymol 2007, 422:47–74.PubMedCrossRef 40. Ubben D, Schmitt R: Tn 1721 derivatives for transposon mutagenesis, restriction mapping and nucleotide sequence analysis. Gene 1986, 41:145–152.PubMedCrossRef 41. Vargas C, Nieto JJ: Genetic tools for the manipulation of moderately halophilic bacteria of the family Halomonadaceae . In Methods in Molecular Biology. Volume 267. Edited by: Balbás P, Lorence A. Totowa, NJ: Humana Press Inc; 2004:183–208. cAMP inhibitor 42. Altenbuchner J, Schmitt R: Transposon Tn 1721 : site-specific recombination generates deletions and inversions. Mol Gen Genet 1983, 190:300–308.PubMedCrossRef 43. Starai VJ, Escalante-Semerena JC: Acetyl-coenzyme A synthetase (AMP forming). Cell Mol Life Sci 2004, 61:2020–2030.PubMedCrossRef 44. Schweikhard ES, Kuhlmann SI, Kunte HJ, Grammann K, Ziegler CM: Structure and function of the universal stress protein TeaD and its role in regulating the ectoine transporter TeaABC of Halomonas elongata DSM 2581T. Biochemistry 2010, 49:2194–2204.PubMedCrossRef 45. Jung H: The sodium/substrate symporter family: structural and functional features. FEBS Lett 2002, 529:73–77.PubMedCrossRef 46. Vargas C, Coronado MJ, Ventosa A, Nieto JJ: Host range, stability, and compatibility of broad host-range-plasmids and a shuttle vector in moderately halophilic bacteria.

PubMedCrossRef 8. Nugent R, Krohn M, Hillier S: Reliability of diagnosing bacterial vaginosis is improved by a standardized method of gram stain interpretation. J Clin Microbiol 1991, 29:297–301.PubMed 9. Hugenholtz P, Goebel BM, Pace NR: Impact of culture-independent studies on the emerging phylogenetic view of bacterial diversity. J Bacteriol 1998, 180:4765–4774.PubMed 10. Sha BE, Chen HY, Wang QJ, Zariffard MR, Cohen MH, Spear GT: Utility of Amsel criteria, Nugent

score, and quantitative PCR for Gardnerella vaginalis, Mycoplasma hominis, and Lactobacillus spp. for diagnosis of bacterial vaginosis in human immunodeficiency virus-infected women. J Clin Microbiol 2005, 43:4607–4612.PubMedCrossRef 11. Verhelst R, Verstraelen H, Claeys G, Verschraegen G, Delanghe J, Van Simaey L, De Ganck C, Temmerman M, Vaneechoutte M: Cloning of 16 S rRNA genes amplified X-396 from normal and disturbed vaginal microflora suggests a strong association between Atopobium vaginae, Gardnerella vaginalis and bacterial vaginosis. BMC Microbiol 2004, 4:16.PubMedCrossRef 12. Fredricks DN, Fiedler TL, Thomas KK, Oakley BB, Marrazzo JM: Targeted PCR for detection of vaginal bacteria associated with

bacterial vaginosis. J Clin Microbiol 2007, 45:3270–3276.PubMedCrossRef 13. Hummelen R, Fernandes MDX-1106 AD, Macklaim JM, Dickson RJ, Changalucha J, Gloor GB, Reid G: Deep sequencing of the vaginal microbiota of women with HIV. PLoS One 2010, 5:e12078.PubMedCrossRef 14. Ravel J, Gajer P, Abdo Z, Schneider GM, Koenig SS, McCulle SL,

Karlebach S, Gorle R, Russell J, Tacket CO, Brotman RM, Davis CC, Ault K, Peralta L, Forney LJ: Vaginal microbiome of reproductive-age women. Proc Natl Acad Sci USA 2011,108(Suppl 1):4680–4687.PubMedCrossRef 15. Spear GT, Gilbert D, Landay AL, Zariffard R, French AL, Patel P, Gillevet PM: Pyrosequencing of the genital microbiotas of HIV-seropositive and Cediranib (AZD2171) -seronegative women reveals Lactobacillus iners as the predominant Lactobacillus Species. Appl Environ Microbiol 2011, 77:378–381.PubMedCrossRef 16. Zhou X, Brown CJ, Abdo Z, Davis CC, Hansmann MA, Joyce P, Foster JA, Forney LJ: Differences in the composition of vaginal microbial communities found in healthy Caucasian and black women. ISME J 2007, 1:121–133.PubMedCrossRef 17. Lamont R, Sobel J, Akins R, Hassan S, Chaiworapongsa T, Kusanovic J, Romero R: The vaginal microbiome: new information about genital tract flora using molecular based techniques. BJOG 2011, 118:533–549.PubMedCrossRef 18. Srinivasan S, Liu C, Mitchell CM, Fiedler TL, Thomas KK, Agnew KJ, Marrazzo JM, Fredricks DN: Temporal variability of human vaginal bacteria and relationship with bacterial vaginosis. PLoS One 2010, 5:e10197.PubMedCrossRef 19. Verstraelen H, Verhelst R, Claeys G, De Backer E, Temmerman M, Vaneechoutte M: Longitudinal analysis of the vaginal microflora in pregnancy suggests that L. crispatus promotes the stability of the normal vaginal microflora and that L. gasseri and/or L.